查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1513926

全球胆固醇检测市场

Cholesterol Testing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 273 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球胆固醇检测市场预计将达到 317 亿美元

全球胆固醇检测市场预计 2023 年为 233 亿美元，预计到 2030 年将达到 317 亿美元，2023 年至 2030 年复合年增长率为 4.5%。诊断中心最终用途是本报告分析的细分市场之一，预计复合年增长率为 5.7%，到分析期结束时将达到 116 亿美元。在分析期间，医生/提供者/医院最终用途细分市场的复合年增长率预计为 4.4%。

美国市场预估成长67亿美元，中国复合年增长率7.8%

到 2023 年，美国胆固醇检测市场预计将达到 67 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达59亿美元，2023-2030年分析期间复合年增长率为7.8%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 1.4% 和 5.2%。在欧洲，德国的复合年增长率预计为 2.4%。

全球胆固醇检测市场趋势与驱动因素总结

胆固醇检测是预防性医疗保健的重要组成部分，可以透过测量血液胆固醇和三酸甘油酯水平来评估个人心臟病的风险。由于不良饮食、缺乏运动和吸烟等生活习惯的影响，全球心血管疾病 (CVD) 盛行率不断上升，对胆固醇检测的需求不断增加。透过胆固醇检测进行早期发现对于及时干预以预防严重的心臟疾病至关重要。健康宣传活动和倡议的推广提高了公众意识和教育，越来越多的人意识到监测胆固醇水平和积极参与定期健康检查的重要性。

胆固醇检测市场的成长得益于多种因素，包括提高检测便利性和准确性的技术进步、与数位健康平台的整合以及越来越多的政府建议对成人进行定期筛检。技术创新已经开发出可携式、用户友好的设备，使个人能够在家中监测胆固醇水平，从而减少频繁就诊的需要。此外，胆固醇检测和数位医疗记录的整合增强了患者资料的管理和跟踪，从而实现个人化和及时的护理。胆固醇检测和数位医疗记录的整合增强了患者资料的管理和跟踪，并为每位患者提供及时、个人化的护理。

护理点 (POC) 的成长趋势可提供即时结果，促进医疗保健提供者和患者之间就治疗方法进行及时对话。这种趋势对于社区健康机构和药局尤其有利。此外，消费者主导的个人健康监测运动日益兴起，刺激了非处方胆固醇检测套组和穿戴式健康设备的成长。由雇主和保险公司赞助的预防性医疗保健计划也纳入了胆固醇测试，以透过及早解决潜在的健康问题来改善员工的健康状况并降低医疗保健成本。

受访企业范例（共42例）

  • Abbott Laboratories
  • AccuTech LLC
  • Akers Biosciences Inc.
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories Inc.
  • Boston Heart Diagnostics Corporation
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd.
  • Home Access Health Corporation
  • Laboratory Corporation of America（R）Holdings
  • PTS Diagnostics
  • Quest Diagnostics Inc.
  • Randox Laboratories Ltd.
  • Sekisui Diagnostics LLC
  • Siemens Healthineers
  • Sigma-Aldrich Corp.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP-3403

Global Cholesterol Testing Market to Reach US$31.7 Billion by 2030

The global market for Cholesterol Testing estimated at US$23.3 Billion in the year 2023, is expected to reach US$31.7 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Diagnostic Centers End-Use, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$11.6 Billion by the end of the analysis period. Growth in the Physicians / Providers & Hospitals End-Use segment is estimated at 4.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.7 Billion While China is Forecast to Grow at 7.8% CAGR

The Cholesterol Testing market in the U.S. is estimated at US$6.7 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$5.9 Billion by the year 2030 trailing a CAGR of 7.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.4% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.4% CAGR.

Global Cholesterol Testing Market - Key Trends and Drivers Summarized

Cholesterol testing is a crucial component of preventive healthcare, enabling the assessment of an individual's risk for heart disease by measuring cholesterol and triglyceride levels in the blood. The demand for cholesterol testing is expanding, driven by the increasing global incidence of cardiovascular diseases (CVDs) influenced by lifestyle factors such as poor diet, lack of physical activity, and smoking. Early detection through cholesterol testing is essential for timely interventions to prevent severe cardiac conditions. With growing public awareness and education, facilitated by health campaigns and initiatives, more people are recognizing the importance of monitoring cholesterol levels and are proactively participating in regular health screenings.

The cholesterol testing market is experiencing growth due to several factors: technological advancements that enhance the convenience and accuracy of testing, integration with digital health platforms, and increasing government recommendations for regular screenings in adults. Technological innovations have led to the development of portable and user-friendly devices that allow individuals to monitor their cholesterol levels at home, reducing the need for frequent healthcare visits. Additionally, the integration of cholesterol testing with digital health records enhances the management and tracking of patient data, enabling personalized and timely care. This integration supports remote patient monitoring, allowing healthcare providers to consult with patients based on digitally shared test results.

The trend toward point-of-care (POC) cholesterol testing is growing, providing immediate results that facilitate timely discussions between healthcare providers and patients about treatment options. This trend is particularly beneficial in community health settings and pharmacies. Furthermore, there is a rising consumer-driven movement towards personal health monitoring, which has spurred the growth of over-the-counter cholesterol testing kits and wearable health devices. Preventive health management programs, supported by employers and insurance companies, are also incorporating cholesterol testing to improve employee health outcomes and reduce healthcare costs by addressing potential health issues early.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories
  • AccuTech LLC
  • Akers Biosciences Inc.
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories Inc.
  • Boston Heart Diagnostics Corporation
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd.
  • Home Access Health Corporation
  • Laboratory Corporation of America(R) Holdings
  • PTS Diagnostics
  • Quest Diagnostics Inc.
  • Randox Laboratories Ltd.
  • Sekisui Diagnostics LLC
  • Siemens Healthineers
  • Sigma-Aldrich Corp.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Cholesterol Testing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Cardiovascular Diseases Strengthens Business Case for Cholesterol Testing
    • Growing Awareness of the Importance of Cholesterol Management Drives Adoption Across Various Demographics
    • Advances in Diagnostic Technology Propel Growth of Cholesterol Testing Market
    • Increasing Adoption of Home Testing Kits Expands Addressable Market Opportunity for Cholesterol Testing
    • Growth in Preventive Healthcare Awareness Generates Demand for Regular Cholesterol Monitoring
    • Expansion of Telemedicine and Remote Monitoring Sustains Growth in Cholesterol Testing Market
    • Integration of AI and Machine Learning in Diagnostics Enhances Cholesterol Test Accuracy
    • Technological Developments in Portable and Wearable Devices Propel Market Expansion for Cholesterol Testing
    • Emphasis on Reducing Healthcare Costs Drives Adoption of Cost-Effective Cholesterol Testing Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cholesterol Testing Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cholesterol Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cholesterol Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Physicians / Providers & Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Physicians / Providers & Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Physicians / Providers & Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Government Agencies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Government Agencies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Government Agencies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2014, 2024 & 2030
  • JAPAN
    • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2014, 2024 & 2030
  • CHINA
    • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: China 16-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2014, 2024 & 2030
  • EUROPE
    • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Cholesterol Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Cholesterol Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2014, 2024 & 2030
  • FRANCE
    • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: France 16-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2014, 2024 & 2030
  • GERMANY
    • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Spain 16-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Russia 16-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Cholesterol Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Cholesterol Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Australia 16-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2014, 2024 & 2030
  • INDIA
    • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: India 16-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: South Korea 16-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Cholesterol Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Cholesterol Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Argentina 16-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Brazil 16-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Mexico 16-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Latin America 16-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Cholesterol Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Cholesterol Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Iran 16-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Israel 16-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Saudi Arabia 16-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: UAE 16-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Middle East 16-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2014, 2024 & 2030
  • AFRICA
    • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Africa 16-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2014, 2024 & 2030

IV. COMPETITION